Alpha-Klotho long-range (LR) research formulations and recombinant constructs serve as essential molecular tools for investigating fibroblast growth factor (FGF) coreceptor signaling, phosphate regulation, and cellular aging pathways. This design guide outlines critical experimental protocols, receptor binding dynamics, and reagent purity benchmarks for in vitro assay development.
Alpha-Klotho long-range (LR) research formulations and recombinant constructs serve as essential molecular tools for investigating fibroblast growth factor (FGF) coreceptor signaling, phosphate regulation, and cellular aging pathways. This design guide outlines critical experimental protocols, receptor binding dynamics, and reagent purity benchmarks for in vitro assay development.
In laboratory research, alpha klotho lr refers to high-purity Alpha-Klotho Long Range recombinant protein constructs or specialized ligand-receptor assay reagents utilized to investigate fibroblast growth factor 23 (FGF23) co-receptor signaling, mineral homeostasis, and cellular senescence pathways. These formulations enable precise binding kinetics, enzyme-linked immunosorbent assays (ELISA), and structural interaction studies in cell-free or cell-culture experimental models.
Alpha-Klotho is a single-pass transmembrane protein predominantly expressed in renal distal convoluted tubules, choroid plexus, and parathyroid glands. The extracellular domain consists of two internal repeats, termed KL1 and KL2, which exhibit sequence homology to family 1 glycosidases. When evaluating alpha klotho research in controlled laboratory environments, researchers utilize long-range or full-length extracellular constructs to preserve the native spatial conformation required for high-affinity binding to fibroblast growth factor receptors (FGFRs).
The molecular architecture of Alpha-Klotho is fundamental to its role as an obligate coreceptor. Native transmembrane Alpha-Klotho forms a binary complex with specific FGFRs (primarily FGFR1c, FGFR3c, and FGFR4), dramatically increasing their affinity for circulating FGF23. In vitro crystal structure analyses demonstrate that the KL1 and KL2 domains cooperatively envelope FGF23, creating a composite binding pocket that stabilizes the FGFR-Klotho-FGF23 ternary complex.
Soluble Alpha-Klotho constructs generated via alternative splicing or proteolytic cleavage by metalloproteinases (ADAM10 and ADAM17) lack the transmembrane and cytoplasmic tails. Research assays investigating cleavage kinetics require highly characterized long-range recombinant proteins to differentiate between membrane-bound coreceptor activation and paracrine/endocrine enzymatic functions attributed to the circulating sialidase-like extracellular fragment.
Developing robust quantitative assays for Alpha-Klotho requires careful selection of assay formats, detection antibodies, and recombinant standards. Surface Plasmon Resonance (SPR) and Bio-Layer Interferometry (BLI) assays demand ultra-pure, monomeric alpha klotho lr constructs to accurately determine dissociation constants ($K_d$) for FGFR isoforms without mass-transport limitations caused by aggregation.
For sandwich ELISA platforms, epitope mapping of capture and detection antibodies is vital. Antibodies targeting the junction between the KL1 and KL2 domains often yield superior specificity when quantifying intact soluble forms, whereas single-domain antibodies may cross-react with isolated cleavage fragments. Researchers consulting the PX1 research library can review analytical specifications for optimizing signal-to-noise ratios across varied biological matrices.
Proper preparation of lyophilized Alpha-Klotho reagents is crucial to preserve tertiary structure and prevent non-specific adsorption. Reconstitution should be performed using sterile, deionized water or phosphate-buffered saline (PBS, pH 7.4) to achieve a stock concentration not lower than 100 µg/mL. Allowing the vial to sit at room temperature for 10–15 minutes post-reconstitution followed by gentle inversion—avoiding vortexing—ensures complete dissolution.
Carrier proteins such as 0.1% Bovine Serum Albumin (BSA) or Human Serum Albumin (HSA) should be incorporated into secondary dilution buffers when working at low concentrations (< 10 µg/mL) to minimize loss to container surfaces. Detailed protocol adjustments can be evaluated using standard reconstitution guidelines to maintain precise molarities during microplate setup.
To ensure reproducibility in preclinical research, assay performance relies directly on reagent purity, batch-to-batch consistency, and physical stability. Substandard reagents containing aggregated proteins or endotoxin contamination can artifactually alter cell signaling cascades and ligand binding assays.
PX1 Research enforces rigorous quality assurance metrics for all research compounds and recombinant reagents:
• High Purity Verification: Every lot undergoes Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity levels ≥ 98%. • Mass Spectrometry Identity: Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) or LC-MS confirms exact molecular weight and structural integrity. • Endotoxin Testing: Quantitative Chromogenic LAL assays ensure endotoxin levels remain strictly < 0.01 EU/µg to prevent immune receptor activation in cell culture. • Lot Traceability & Documentation: Comprehensive Certificates of Analysis (COA) detailing HPLC/MS spectrums are provided per lot. • USA Manufacturing & Compliance: Formulated in ISO 17025 accredited, GMP-compliant facilities in the United States. • Reliable Logistics: Immediate fulfillment with same-day shipping (Monday–Friday) directly from centralized distribution hubs in California and Arizona.
When designing pathways assays for longevity and metabolic research, investigators frequently compare Alpha-Klotho against other distinct molecular targets. While Alpha-Klotho acts via FGFR coreceptor signaling to modulate phosphate transport and oxidative stress response pathways, research peptides such as Epitalon target telomerase activation pathways, and FOXO4-DRI selectively targets p53-mediated apoptotic signaling in senescent cells. Furthermore, mitochondrial-targeted peptides like SS-31 peptide focus on cardiolipin stabilization within the inner mitochondrial membrane.
Understanding these mechanistic distinctions is essential when constructing multi-target in vitro panels. While Klotho signaling influences systemic phosphate homeostasis and Wnt/β-catenin suppression, direct mitochondrial targeting or senolytic peptide interference operates via separate, non-overlapping signal cascades. Reviewing comparative data across longevity research compounds aids in selecting the appropriate analytical endpoints.
Assay interference in alpha klotho lr experiments often stems from proteolytic cleavage by endogenous ADAM metalloproteinases present in primary cell cultures. When conducting long-term incubation assays (24–72 hours), incorporating broad-spectrum or selective metalloproteinase inhibitors can stabilize cell-surface Klotho expressions, enabling precise quantification of membrane-bound activity.
In cell-free binding assays, divalent cations such as $Ca^{2+}$ and $Mg^{2+}$ must be tightly controlled. The enzymatic glucosidase-like domain activity of soluble Klotho, although weak compared to canonical glycosidases, exhibits structural dependency on ionic strength and pH. Maintaining standard physiological buffer conditions (pH 7.2–7.4, 150 mM NaCl) minimizes non-specific electrostatic interactions.
Lyophilized Alpha-Klotho constructs retain stability at -20°C to -80°C for extended periods. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene microcentrifuge tubes to eliminate repeated freeze-thaw cycles, which induce protein aggregation and loss of coreceptor binding affinity.
Reconstituted aliquots stored at 2°C to 8°C remain stable for up to 7 days, whereas long-term storage requires -80°C in the presence of a carrier protein or cryoprotectant (e.g., 5% trehalose or glycerol). Researchers investigating growth factor kinetics or auxiliary secretagogues like GHRP-2 must validate storage protocols to maintain identical biological activity across multi-week assay runs.
Scaling Alpha-Klotho assays to 384-well or 1536-well high-throughput screening (HTS) formats requires large, uniform reagent lots to eliminate batch-to-batch variation across screening runs. Inconsistent lot characteristics introduce systemic noise that distorts statistical Z-factor calculations in compound library screens.
Principal investigators and laboratory managers requiring scalable reagent supplies can utilize the PX1 wholesale program to reserve single-lot batches with pre-validated HPLC/MS COAs. Establishing long-term batch reservations ensures consistent signal intensity, reproducible baseline binding curves, and reliable standard controls throughout extensive screening campaigns.
What does alpha klotho lr stand for in laboratory research?
In laboratory research, alpha klotho lr typically refers to Alpha-Klotho Long Range recombinant constructs or specialized ligand-receptor assay reagents optimized for evaluating FGF23 signaling, coreceptor binding kinetics, and extracellular domain dynamics in vitro.
Is Alpha-Klotho LR intended for human administration?
No. Alpha-Klotho LR and all associated research compounds from PX1 Research are strictly designated for laboratory research use only. They are not for human or animal consumption, diagnostic use, or therapeutic application.
What is the difference between transmembrane and soluble Alpha-Klotho?
Transmembrane Alpha-Klotho acts as an obligate coreceptor for FGF23 on target cell membranes. Soluble Alpha-Klotho is generated by proteolytic cleavage of the extracellular domain and circulates independently, functioning via endocrine and paracrine mechanisms.
How should lyophilized Alpha-Klotho LR be reconstituted?
Reconstitution should be conducted using sterile deionized water or PBS (pH 7.4) to a minimum concentration of 100 µg/mL. Allow 10–15 minutes at room temperature for complete dissolution and gently invert to mix without vortexing.
What purity levels are required for quantitative binding assays?
Quantitative binding assays like SPR or ELISA require protein purity ≥ 98% as determined by RP-HPLC, alongside mass spectrometry verification and endotoxin levels < 0.01 EU/µg to prevent non-specific baseline noise.
Why is endotoxin testing critical for Alpha-Klotho cell culture assays?
Endotoxins (lipopolysaccharides) activate Toll-like receptors (TLR4) in cell cultures, triggering inflammatory cascades that interfere with coreceptor signal transduction and obscure accurate experimental readouts.
How should reconstituted Alpha-Klotho solutions be stored?
Reconstituted solutions should be aliquoted into single-use tubes to avoid freeze-thaw cycles. Aliquots can be stored at 2–8°C for up to 7 days or at -80°C for long-term stability.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in ISO 17025 accredited facilities in the USA and shipped same-day (Monday–Friday) from distribution centers located in California and Arizona.
Can Alpha-Klotho LR be used in multi-target longevity signaling panels?
Yes, in vitro panels frequently combine Alpha-Klotho coreceptor assays with other cellular senescence or mitochondrial targets to study parallel pathways in controlled biological models.
How can laboratories procure bulk single-lot quantities of Alpha-Klotho LR?
Laboratories conducting high-throughput screening can request single-lot reservations and bulk procurement through the PX1 wholesale program to ensure consistent batch metrics across large study volumes.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.